54 results
Page 2 of 3
6-K
EX-99.1
ss3gw7os
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
424B3
oiy4e2 cr8fg10dnzhm
6 Aug 21
Prospectus supplement
8:17am
424B3
w3pab57xthzxqb9
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
sipwtpcsqbbd
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
F-4
eb5tbkor6er48k
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
ha1d36jy7dc bb0l
2 Jun 21
Prospectus supplement
10:10am
424B3
pgenz
2 Jun 21
Prospectus supplement
10:09am
424B3
u5fog2z67in05 qff
2 Jun 21
Prospectus supplement
10:08am
425
60owa dm8n5l2
5 May 21
Business combination disclosure
5:26pm
425
upiz6awbs8eo3j7uvjo
5 May 21
Business combination disclosure
5:25pm
425
0iujzczzlotw
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
uybymx5 yn1pekdsji15
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
vl76widc
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
8tpz 1mr948
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
jatm8g
30 Apr 21
Annual report (foreign)
12:53pm
424B3
gd0e6725cfneg70
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
t5whlvo2u 4vldh
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
5jhwro g8n
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
jhr57c v1
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
x6bkh0rx76jr3by
8 Jan 21
Registration statement (foreign)
4:58pm